Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Sturdy Memorial and Column Health Announce Partnership to Provide the Attleboro Community with Immediate Access to Innovative, Best in Class Outpatient Addiction Treatment

Published

on

Reading Time: 3 minutes

ATTLEBORO, Mass.–(BUSINESS WIRE)–Column Health, a healthcare organization providing an innovative model
of outpatient addiction treatment, has partnered with Sturdy Memorial
Hospital in Attleboro to provide comprehensive, best in class care for
those with substance use disorders in Southeastern Massachusetts. The
joint venture, Column Health | Sturdy Memorial, seeks to meaningfully
impact the lives of those struggling with Substance Use Disorder and
Addiction.

The collaborative approach between the two organizations is designed to
meet patients where they are, and to deliver care when and where they
need it most. It combines immediate enrollment into the substance use
disorder treatment program from Sturdy’s Emergency Department with a
direct transfer to the outpatient program, daytime drop-in appointment
availability, no waiting lists for addiction treatment and is covered
for patients with MassHealth.

Column Health and Sturdy’s partnership is based on shared values of
providing the highest quality comprehensive treatment and sustained
recovery for people with substance use disorders, while driving positive
clinical outcomes for patients in their communities. The program is
based upon Column Health’s model of comprehensive, community based, data
driven, outcomes focused, and immediately accessible substance use
disorder and addiction treatment to any person who wants it, a model
which has proven to drive successful patient outcomes in each of their
six locations throughout the Boston area.

“We’ve watched people close to us across our community succumb to the
disease of addiction and felt ethically compelled to do more,” shared
Column Health CEO Colin Beatty. “We started Column Health to
address the lack of adequate, immediately available, humane,
evidence-based and clinically-driven treatment options. Our Column
Health team is making incredible progress helping people across our
community, collaboratively expanding treatment options for our loved
ones and fellow community members and partnering with Sturdy Memorial
Hospital will enable us to provide that best in class treatment to
patients in real time, as they show up to the ED, or their primary care
physician’s office. Together we’ll be able to move our comprehensive
clinical care model out to patients in a hard hit region of
Massachusetts.”

“As a community hospital, we have seen the effects of the opioid crisis
on our patients first hand,” shares Dr. Brian Patel, Chief of Emergency
Services and Associate Chief Quality Officer at Sturdy Memorial
Hospital. “Patients present time and again to the ED after an overdose,
many of them looking for help with their addiction. And while we’ve
developed numerous initiatives within the Hospital to help address
substance use disorder and reduce prescribing of opioids to patients, we
recognize that in order to make an impact, we need to expand our
efforts. Our partnership with Column Health allows us to provide our
patients with a consistent and comprehensive long term treatment plan
that addresses both substance use and mental health disorders in a
stigma-free environment. This program will provide a much needed level
of care that our patients have not had access to locally, until now.”

Column Health | Sturdy Memorial will be hosting a ribbon cutting and
Open House on Tuesday, May 14, 2019 from 4:00-7:00pm. Attendees will be
able to take a tour of the treatment center and meet members of the team.

About Sturdy Memorial

Sturdy Memorial Hospital is a locally controlled, not-for-profit,
132-bed acute care community hospital dedicated to providing a broad
range of health care services to the residents of the communities it
serves. Sturdy’s mission is to provide high quality care to the sick and
injured, on both an inpatient and outpatient basis, without regard to
race, creed, national origin, age, gender, disability or ability to pay.
The primary commitment of Sturdy Memorial Hospital is to serve the
residents of Attleboro, Foxboro, Mansfield, North Attleboro, Norfolk,
Norton, Plainville, Seekonk, Sharon, Rehoboth, Walpole, Wrentham, and
nearby Rhode Island.

About Column Health

Column Health is a new healthcare company that has developed an
innovative model of treatment for full recovery from substance use
disorders. Column Health has a rapidly expanding network of outpatient
mental health clinics focused on innovative and humane treatment that
provides outcomes focused treatment for patients struggling with the
disease of addiction. Column Health offers a full suite of mental health
and substance use disorder treatment related services including
Medication Assisted Recovery Treatment, psychotherapy, integrated lab
testing, detoxification, and medication management in beautifully
appointed, technology-enabled, state-of-the-art medical clinic settings.
By integrating a comprehensive range of treatment modalities to properly
treat mental illness, we provide customized plans for patients seeking a
full range of care in a single, convenient location; our one-stop clinic
model enables better coordination of care and facilitates improved
effectiveness of the program and patient outcomes.

Column Health recognizes that successful outcomes in mental illness and
substance use disorder treatment are built on many factors, especially
the interaction with and support of an extended community of people,
programs, and places well beyond the walls of the clinic. We also
recognize that our success is based on the success of our patients and
of our extended community. Our alignment of goals and community sets
Column Health apart from other substance use treatment models. Column
Health welcomes opportunities to partner with other providers,
regulators and communities, as together we look for ways to provide
innovative care options to patients and reduce the stigma of substance
use disorders.

Contacts

For Sturdy Memorial
Public Relations at 508.236.8020

For Column Health
John Gates
617-548-8972
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading

Humboldt

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Published

on

humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”

Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”

About Humboldt Seed Company

Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.

For more information visit https://humboldtseedcompany.com/.

About Apollo Green

Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics. 

For more information visit https://apollogreen.com/.

Media contact
Jaana Prall
[email protected] 

Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html

Continue Reading

Cannabis

Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania